"The proposed Pharmaceutical Medicine Training Programme provides a comprehensive solution for the complex needs of integrated drug development for all professionals involved, incl. physicians, pharmaceutical scientists,biologists, biometricians, health economists, and safety and regulatory scientists from universities, regulatory agencies, large, middle-sized and small pharmaceutical enterprises, and allied companies providing contract research services, finance, clinical supplies, product manufacture and information, as well as from research ethics committees – as set out in the IMI Call Text Project # 16, p. 88-99. Eventually, this broad-based training platform programme will be tailored towards greatly enhancing the skillsetsand competencies of all key contributors to the drug development and regulatory processes using the latestscientific approaches to base the development of medicines on pathophysiology, safety and risk-awareness patient and population-based benefit as well as to make the process faster, more economical and more competitive with other parts of the world than hitherto. To address this, a pan-European comprehensive multi-modular training programme at the Master level – Master of Advanced Studies in Pharmaceutical Medicine/Drug Development Sciences (MDDS) – and other targeted programmes will be targeted for Specialists within this IMI-programme. The programme will comply with the Bologna credit and title system, and will be well-structured, self-sustaining and underpinned by a quality management system."
Call for proposal
See other projects for this call